Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Work In Process (2016 - 2018)

Lifecore Biomedical, Inc. \De\ has reported Work In Process over the past 7 years, most recently at $3.1 million for Q4 2018.

  • For Q4 2018, Work In Process fell 34.24% year-over-year to $3.1 million; the TTM value through Nov 2018 reached $3.1 million, down 34.24%, while the annual FY2018 figure was $3.7 million, 6.53% up from the prior year.
  • Work In Process for Q4 2018 was $3.1 million at Lifecore Biomedical, Inc. \De\, down from $3.1 million in the prior quarter.
  • Over five years, Work In Process peaked at $13.0 million in Q4 2016 and troughed at $1.9 million in Q2 2015.
  • A 5-year average of $3.8 million and a median of $3.3 million in 2014 define the central range for Work In Process.
  • Biggest five-year swings in Work In Process: skyrocketed 265.69% in 2016 and later plummeted 63.95% in 2017.
  • Year by year, Work In Process stood at $4.0 million in 2014, then dropped by 11.86% to $3.6 million in 2015, then skyrocketed by 265.69% to $13.0 million in 2016, then plummeted by 63.95% to $4.7 million in 2017, then crashed by 34.24% to $3.1 million in 2018.
  • Business Quant data shows Work In Process for LFCR at $3.1 million in Q4 2018, $3.1 million in Q3 2018, and $3.7 million in Q2 2018.